Dr. Taylor on the Current Treatment Landscape for Endometrial Cancer

Alexandra Taylor, MD
Published: Thursday, Dec 21, 2017



Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the current treatment landscape of advanced endometrial cancer.

According to Taylor, the mainstay of treatment is chemotherapy. It is important to give systemic treatment, but if a patient presents with disease that can be surgically removed, there is a debate about whether they should have surgery first.

Ideally, a patient can have complete cytoreduction, meaning they undergo surgery and then receive chemotherapy, explains Taylor. The results with surgery when the patient undergoes cytoreduction can be associated with a high risk of complications.
 


Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the current treatment landscape of advanced endometrial cancer.

According to Taylor, the mainstay of treatment is chemotherapy. It is important to give systemic treatment, but if a patient presents with disease that can be surgically removed, there is a debate about whether they should have surgery first.

Ideally, a patient can have complete cytoreduction, meaning they undergo surgery and then receive chemotherapy, explains Taylor. The results with surgery when the patient undergoes cytoreduction can be associated with a high risk of complications.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Redefining Ovarian Cancer Treatment Paradigms by Maximizing Therapeutic Outcomes with PARP InhibitorsSep 29, 20182.0
Community Practice Connections™: 1st Annual School of Nursing Oncology™Oct 31, 20181.5
Publication Bottom Border
Border Publication
x